DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Clemens PL, Yan X, Lokhorst HM, Lonial S, Losic N, Khan I. et al.
Pharmacokinetics of daratumumab following intravenous infusion in relapsed or refractory multiple myeloma after prior proteasome inhibitor and immunomodulatory drug treatment.
Clin Pharmacokinet 2017;
56: 915-24
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.